Fundacion Clinic per a la Recerca Biomédica

A Clinical Trial of Analytical Treatment Interruption in People With HIV With a Highly Favourable Profile

Role: lead

Assessment of the Impact of Type of Probiotic, Delivery Type and Feeding Type on Baby's Microbiota After Dysbiotic Delivery

Role: lead

Usefulness of Thromboelastography as a Predictor of Prognosis in Patients Undergoing Surgery for Glial Tumors and of the Risk of Postoperative Thromboembolic Disease (GliTEM)

Role: lead

A Mediterranean Diet-Based Culinary Intervention in Adults With Metabolic Syndrome

Role: lead

Efficacy and Tolerability of a Simethicone-containing Evacuating Solution for Colorectal Cancer Screening Colonoscopy

Role: lead

Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer

Role: collaborator

Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC

Role: lead

Oral Antimicrobial Treatment vs. Outpatient Parenteral for Infective Endocarditis

Role: lead

First in Human Pilot Study to Assess the Safety and Efficacy of Dendritic Cells Loaded With Frameshift Derived Neopeptides for the Prevention of Cancer in of Lynch Syndrome Carriers

Role: lead

Application of Radiomics for Diagnosis and Follow-up of Cardiovascular Device Infections: PREDICT Study

Role: lead

CD5CAR-NK Cells for Refractory Invasive Mold Disease

Role: lead

Study on Sexual Health and Self-perceived Quality of Life (PROMs) in Patients Treated for Cervical Cancer

Role: lead

Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

Role: lead

Pharmacokinetic Characterization of Tartaric Acid in Humans

Role: lead

Darbepoetin in Patients Candidates for Liver Transplant. (EPO-LT Trial)

Role: lead

Study to Evaluate the Efficacy of Intravenous Administration of Human Albumin Versus Saline Solution in Patients With descompénsate Cirrhosis Grade 1B or Higher Renal Failure

Role: lead

Clinical Trial to Evaluate the Efficacy, Pharmacokinetics (PK) Interactions and Safety of Dolutegravir Plus 2 Nucleoside Reverse Transcriptase Inhibitors (NRTIs) in HIV-1-Infected Solid Organ Transplant Patients

Role: lead

Epigallocatechin Gallate (EGCG) to Improve Cognitive Performance in Foetal Alcohol Syndrome (FAS) Children

Role: lead

Quantification Tools for a Novel Tau PET Marker in a Rare Neurological Disease: 18F-PI-2620 in Progressive Supranuclear Palsy

Role: lead

Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM

Role: collaborator